CERo Therapeutics (CERO) Competitors $2.31 -0.03 (-1.28%) Closing price 04:00 PM EasternExtended Trading$2.33 +0.02 (+0.65%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends CERO vs. MIRA, APRE, CYTH, BFRG, BTAI, CARM, PIRS, MEIP, AFMD, and SNTIShould you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include MIRA Pharmaceuticals (MIRA), Aprea Therapeutics (APRE), Cyclo Therapeutics (CYTH), Bullfrog AI (BFRG), BioXcel Therapeutics (BTAI), Carisma Therapeutics (CARM), Pieris Pharmaceuticals (PIRS), MEI Pharma (MEIP), Affimed (AFMD), and Senti Biosciences (SNTI). These companies are all part of the "pharmaceutical products" industry. CERo Therapeutics vs. MIRA Pharmaceuticals Aprea Therapeutics Cyclo Therapeutics Bullfrog AI BioXcel Therapeutics Carisma Therapeutics Pieris Pharmaceuticals MEI Pharma Affimed Senti Biosciences MIRA Pharmaceuticals (NASDAQ:MIRA) and CERo Therapeutics (NASDAQ:CERO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment, community ranking and earnings. Do analysts prefer MIRA or CERO? MIRA Pharmaceuticals presently has a consensus price target of $14.00, suggesting a potential upside of 1,081.43%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts plainly believe MIRA Pharmaceuticals is more favorable than CERo Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33CERo Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of MIRA or CERO? 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. Comparatively, 29.6% of CERo Therapeutics shares are held by institutional investors. 6.7% of MIRA Pharmaceuticals shares are held by insiders. Comparatively, 18.0% of CERo Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, MIRA or CERO? MIRA Pharmaceuticals has a beta of 2.12, suggesting that its share price is 112% more volatile than the S&P 500. Comparatively, CERo Therapeutics has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Is MIRA or CERO more profitable? CERo Therapeutics' return on equity of 0.00% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MIRA PharmaceuticalsN/A -337.44% -280.58% CERo Therapeutics N/A N/A -108.43% Does the media prefer MIRA or CERO? In the previous week, MIRA Pharmaceuticals had 1 more articles in the media than CERo Therapeutics. MarketBeat recorded 1 mentions for MIRA Pharmaceuticals and 0 mentions for CERo Therapeutics. CERo Therapeutics' average media sentiment score of 1.00 beat MIRA Pharmaceuticals' score of 0.26 indicating that CERo Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment MIRA Pharmaceuticals Neutral CERo Therapeutics Positive Which has higher earnings and valuation, MIRA or CERO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMIRA PharmaceuticalsN/AN/A-$11.98M-$0.56-2.12CERo TherapeuticsN/AN/A-$2.54MN/AN/A Does the MarketBeat Community prefer MIRA or CERO? MIRA Pharmaceuticals received 3 more outperform votes than CERo Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformMIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo VotesCERo TherapeuticsN/AN/A SummaryMIRA Pharmaceuticals beats CERo Therapeutics on 8 of the 13 factors compared between the two stocks. Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERO vs. The Competition Export to ExcelMetricCERo TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.61M$2.99B$5.37B$9.10BDividend YieldN/A1.89%5.37%4.00%P/E RatioN/A45.2087.4217.48Price / SalesN/A289.281,281.3978.80Price / CashN/A189.5236.6032.90Price / Book-0.013.964.934.65Net Income-$2.54M-$40.99M$117.96M$224.76M7 Day Performance-14.11%2.61%2.21%2.97%1 Month Performance-57.13%0.04%3.20%4.97%1 Year PerformanceN/A-1.03%26.67%21.85% CERo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CEROCERo TherapeuticsN/A$2.31-1.3%N/AN/A$3.47MN/A0.008Gap UpMIRAMIRA Pharmaceuticals2.7189 of 5 stars$1.18-6.7%$14.00+1,091.5%+45.7%$19.46MN/A-2.102APREAprea Therapeutics3.8342 of 5 stars$3.55-3.0%$15.50+336.6%-28.6%$19.29M$580,000.00-1.267News CoverageGap UpCYTHCyclo Therapeutics1.7853 of 5 stars$0.65+4.3%$0.95+46.2%-51.5%$18.70M$870,725.00-0.729Gap DownBFRGBullfrog AI0.256 of 5 stars$2.12+0.0%N/A-56.6%$18.52M$60,000.00-2.504BTAIBioXcel Therapeutics4.5793 of 5 stars$0.37-1.3%$2.81+655.2%-86.6%$18.48M$2.28M-0.1790CARMCarisma Therapeutics3.6333 of 5 stars$0.44-6.3%$4.94+1,019.2%-80.8%$18.43M$14.92M-0.2820Short Interest ↓Gap DownPIRSPieris Pharmaceuticals0.6848 of 5 stars$13.60-15.7%N/A+2.0%$17.95M$42.81M-1.12140Analyst ForecastGap DownMEIPMEI Pharma4.3496 of 5 stars$2.69-0.4%$7.00+160.2%-39.3%$17.92M$65.30M-0.38100Analyst ForecastNews CoverageAFMDAffimed4.311 of 5 stars$1.10-7.2%$13.50+1,132.9%-80.5%$17.71M$877,000.000.00200Positive NewsGap UpSNTISenti Biosciences2.8745 of 5 stars$3.83-2.5%$10.00+161.1%+11.9%$17.58M$2.56M-0.254Gap Up Related Companies and Tools Related Companies MIRA Alternatives APRE Alternatives CYTH Alternatives BFRG Alternatives BTAI Alternatives CARM Alternatives PIRS Alternatives MEIP Alternatives AFMD Alternatives SNTI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CERO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
